BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

848 related articles for article (PubMed ID: 32706417)

  • 1. Characteristics and roles of severe acute respiratory syndrome coronavirus 2-specific antibodies in patients with different severities of coronavirus 19.
    Huang Z; Chen H; Xue M; Huang H; Zheng P; Luo W; Liang X; Sun B; Zhong N
    Clin Exp Immunol; 2020 Nov; 202(2):210-219. PubMed ID: 32706417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluations of the serological test in the diagnosis of 2019 novel coronavirus (SARS-CoV-2) infections during the COVID-19 outbreak.
    Lin D; Liu L; Zhang M; Hu Y; Yang Q; Guo J; Dai Y; Xu Y; Cai Y; Chen X; Huang K; Zhang Z
    Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2271-2277. PubMed ID: 32681308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation.
    Jääskeläinen AJ; Kuivanen S; Kekäläinen E; Ahava MJ; Loginov R; Kallio-Kokko H; Vapalahti O; Jarva H; Kurkela S; Lappalainen M
    J Clin Virol; 2020 Aug; 129():104512. PubMed ID: 32563180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of adjunctive serological detection to nucleic acid test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection diagnosis.
    Liu R; Liu X; Yuan L; Han H; Shereen MA; Zhen J; Niu Z; Li D; Liu F; Wu K; Luo Z; Zhu C
    Int Immunopharmacol; 2020 Sep; 86():106746. PubMed ID: 32619956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody Detection and Dynamic Characteristics in Patients With Coronavirus Disease 2019.
    Xiang F; Wang X; He X; Peng Z; Yang B; Zhang J; Zhou Q; Ye H; Ma Y; Li H; Wei X; Cai P; Ma WL
    Clin Infect Dis; 2020 Nov; 71(8):1930-1934. PubMed ID: 32306047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal Change of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies in Patients with Coronavirus Disease 2019.
    Zhang G; Nie S; Zhang Z; Zhang Z
    J Infect Dis; 2020 Jun; 222(2):183-188. PubMed ID: 32358956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip.
    Prazuck T; Colin M; Giachè S; Gubavu C; Seve A; Rzepecki V; Chevereau-Choquet M; Kiani C; Rodot V; Lionnet E; Courtellemont L; Guinard J; Pialoux G; Hocqueloux L
    PLoS One; 2020; 15(9):e0237694. PubMed ID: 32941461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of a rapid immunochromatographic test with a chemiluminescence immunoassay for detection of anti-SARS-CoV-2 IgM and IgG.
    Gambino CM; Lo Sasso B; Colomba C; Giglio RV; Agnello L; Bivona G; Ciaccio M
    Biochem Med (Zagreb); 2020 Oct; 30(3):030901. PubMed ID: 33071558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech).
    Nicol T; Lefeuvre C; Serri O; Pivert A; Joubaud F; Dubée V; Kouatchet A; Ducancelle A; Lunel-Fabiani F; Le Guillou-Guillemette H
    J Clin Virol; 2020 Aug; 129():104511. PubMed ID: 32593133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 Antibody Responses Do Not Predict COVID-19 Disease Severity.
    Phipps WS; SoRelle JA; Li QZ; Mahimainathan L; Araj E; Markantonis J; Lacelle C; Balani J; Parikh H; Solow EB; Karp DR; Sarode R; Muthukumar A
    Am J Clin Pathol; 2020 Sep; 154(4):459-465. PubMed ID: 32666092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Peptide-Based Magnetic Chemiluminescence Enzyme Immunoassay for Serological Diagnosis of Coronavirus Disease 2019.
    Cai XF; Chen J; Li Hu J; Long QX; Deng HJ; Liu P; Fan K; Liao P; Liu BZ; Wu GC; Chen YK; Li ZJ; Wang K; Zhang XL; Tian WG; Xiang JL; Du HX; Wang J; Hu Y; Tang N; Lin Y; Ren JH; Huang LY; Wei J; Gan CY; Chen YM; Gao QZ; Chen AM; He CL; Wang DX; Hu P; Zhou FC; Huang AL; Wang DQ
    J Infect Dis; 2020 Jun; 222(2):189-193. PubMed ID: 32382737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal Monitoring of SARS-CoV-2 IgM and IgG Seropositivity to Detect COVID-19.
    Suhandynata RT; Hoffman MA; Kelner MJ; McLawhon RW; Reed SL; Fitzgerald RL
    J Appl Lab Med; 2020 Sep; 5(5):908-920. PubMed ID: 32428207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the performance of SARS-CoV-2 serological tools and their positioning in COVID-19 diagnostic strategies.
    Velay A; Gallais F; Benotmane I; Wendling MJ; Danion F; Collange O; De Sèze J; Schmidt-Mutter C; Schneider F; Bilbault P; Meziani F; Fafi-Kremer S
    Diagn Microbiol Infect Dis; 2020 Dec; 98(4):115181. PubMed ID: 32957073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of lateral flow tests in SARS-CoV-2 infection monitorization.
    Candel FJ; Viñuela-Prieto JM; González Del Castillo J; Barreiro García P; Fragiel Saavedra M; Hernández Píriz A; Jiménez Virumbrales D; Canora Lebrato J; García de Casasola G; Gil Prieto R; San-Román Montero J; Ortega Anselmi J; Barba Martín R; Prados Roa F; Marco Martínez J; Zapatero Gaviria A
    Rev Esp Quimioter; 2020 Aug; 33(4):258-266. PubMed ID: 32492991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients.
    Sun B; Feng Y; Mo X; Zheng P; Wang Q; Li P; Peng P; Liu X; Chen Z; Huang H; Zhang F; Luo W; Niu X; Hu P; Wang L; Peng H; Huang Z; Feng L; Li F; Zhang F; Li F; Zhong N; Chen L
    Emerg Microbes Infect; 2020 Dec; 9(1):940-948. PubMed ID: 32357808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological chemiluminescence immunoassay for the diagnosis of SARS-CoV-2 infection.
    Lijia S; Lihong S; Huabin W; Xiaoping X; Xiaodong L; Yixuan Z; Pin H; Yina X; Xiaoyun S; Junqi W
    J Clin Lab Anal; 2020 Oct; 34(10):e23466. PubMed ID: 32671890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody responses to SARS-CoV-2 in patients with differing severities of coronavirus disease 2019.
    Kowitdamrong E; Puthanakit T; Jantarabenjakul W; Prompetchara E; Suchartlikitwong P; Putcharoen O; Hirankarn N
    PLoS One; 2020; 15(10):e0240502. PubMed ID: 33035234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of Viral Nucleic Acid in Sputum and Feces and Specific IgM/IgG in Serum for the Diagnosis of Coronavirus Disease 2019.
    He Y; Luo J; Yang J; Song J; Wei L; Ma W
    Front Cell Infect Microbiol; 2020; 10():445. PubMed ID: 32850506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of IgG and IgM antibody response in COVID-19 patients.
    Liu X; Wang J; Xu X; Liao G; Chen Y; Hu CH
    Emerg Microbes Infect; 2020 Dec; 9(1):1269-1274. PubMed ID: 32515684
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 43.